ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY
the article presents the results of analysis of the state procurement of the drugs for rare diseases. The analysis was conducted on the basis of 1499 selected trade procedures on rare disease drugs procurement in 2013. The article evaluates the state of competition in procurement of monopoly and alt...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
IRBIS LLC
2015-05-01
|
| Series: | Фармакоэкономика |
| Subjects: | |
| Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/84 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1839584373442084864 |
|---|---|
| author | D. V. Fedyaev V. K. Fedyaeva V. V. Omelyanovsky |
| author_facet | D. V. Fedyaev V. K. Fedyaeva V. V. Omelyanovsky |
| author_sort | D. V. Fedyaev |
| collection | DOAJ |
| description | the article presents the results of analysis of the state procurement of the drugs for rare diseases. The analysis was conducted on the basis of 1499 selected trade procedures on rare disease drugs procurement in 2013. The article evaluates the state of competition in procurement of monopoly and alternative drugs, the level of price reduction as a result of trading, the amount and volume of purchases in the subjects of the Russian Federation. The analysis results show that tender procedures used for the procurement of monopoly drugs are ineffective because of the lack of competition; distributors are not interested in price reduction at noncompetitive procedures. In the procurement of alternative drugs at competitive trade procedures it is possible to reach a high level of price reduction, indicating overpricing of the initial (maximum) contract price of procured drugs. |
| format | Article |
| id | doaj-art-23ab91c46bcd41aeadeb6393dab4bcc8 |
| institution | Matheson Library |
| issn | 2070-4909 2070-4933 |
| language | Russian |
| publishDate | 2015-05-01 |
| publisher | IRBIS LLC |
| record_format | Article |
| series | Фармакоэкономика |
| spelling | doaj-art-23ab91c46bcd41aeadeb6393dab4bcc82025-08-03T19:49:34ZrusIRBIS LLCФармакоэкономика2070-49092070-49332015-05-017431076ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPYD. V. Fedyaev0V. K. Fedyaeva1V. V. Omelyanovsky2Russian Presidential Academy of National Economy and Public Administration, Federal State Educational Institution of Higher Professional Education, Moscow Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution, MoscowRussian Presidential Academy of National Economy and Public Administration, Federal State Educational Institution of Higher Professional Education, Moscow Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution, MoscowRussian Presidential Academy of National Economy and Public Administration, Federal State Educational Institution of Higher Professional Education, Moscow Research Financial Institution of the Ministry of Finance of the Russian Federation, Federal State Budget Institution, Moscowthe article presents the results of analysis of the state procurement of the drugs for rare diseases. The analysis was conducted on the basis of 1499 selected trade procedures on rare disease drugs procurement in 2013. The article evaluates the state of competition in procurement of monopoly and alternative drugs, the level of price reduction as a result of trading, the amount and volume of purchases in the subjects of the Russian Federation. The analysis results show that tender procedures used for the procurement of monopoly drugs are ineffective because of the lack of competition; distributors are not interested in price reduction at noncompetitive procedures. In the procurement of alternative drugs at competitive trade procedures it is possible to reach a high level of price reduction, indicating overpricing of the initial (maximum) contract price of procured drugs.https://www.pharmacoeconomics.ru/jour/article/view/84government procurements of medicinessystem effectiveness of government procurementscontract systemrare diseases |
| spellingShingle | D. V. Fedyaev V. K. Fedyaeva V. V. Omelyanovsky ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY Фармакоэкономика government procurements of medicines system effectiveness of government procurements contract system rare diseases |
| title | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY |
| title_full | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY |
| title_fullStr | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY |
| title_full_unstemmed | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY |
| title_short | ANALYSIS OF GOVERNMENT PROCUREMENTS OF MEDICINES APPLIED IN RARE DISEASES THERAPY |
| title_sort | analysis of government procurements of medicines applied in rare diseases therapy |
| topic | government procurements of medicines system effectiveness of government procurements contract system rare diseases |
| url | https://www.pharmacoeconomics.ru/jour/article/view/84 |
| work_keys_str_mv | AT dvfedyaev analysisofgovernmentprocurementsofmedicinesappliedinrarediseasestherapy AT vkfedyaeva analysisofgovernmentprocurementsofmedicinesappliedinrarediseasestherapy AT vvomelyanovsky analysisofgovernmentprocurementsofmedicinesappliedinrarediseasestherapy |